Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
64.68 +1.78 (+2.83%) 04/22/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 64.68 unch (unch) 16:02 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
62.04
Day High
65.08
Open 63.43
Previous Close 62.90 62.90
Volume 1,028,700 1,028,700
Avg Vol 2,440,655 2,440,655
Stochastic %K 4.31% 4.31%
Weighted Alpha +104.41 +104.41
5-Day Change -2.75 (-4.08%) -2.75 (-4.08%)
52-Week Range 22.00 - 117.33 22.00 - 117.33
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,636,138
  • Shares Outstanding, K 105,503
  • Annual Sales, $ 675,040 K
  • Annual Income, $ 141,210 K
  • EBIT $ 137 M
  • EBITDA $ 127 M
  • 60-Month Beta 0.15
  • Price/Sales 9.73
  • Price/Cash Flow 50.11
  • Price/Book 9.60

Options Overview Details

View History
  • Implied Volatility 72.46% ( +0.64%)
  • Historical Volatility 230.29%
  • IV Percentile 56%
  • IV Rank 41.00%
  • IV High 156.92% on 05/17/24
  • IV Low 13.78% on 08/16/24
  • Put/Call Vol Ratio 0.47
  • Today's Volume 1,169
  • Volume Avg (30-Day) 3,162
  • Put/Call OI Ratio 1.43
  • Today's Open Interest 33,779
  • Open Int (30-Day) 50,721

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.17
  • Number of Estimates 4
  • High Estimate 0.18
  • Low Estimate 0.15
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -32.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.79 +20.25%
on 03/28/25
Period Open: 58.66
117.33 -44.87%
on 03/31/25
+6.02 (+10.26%)
since 03/21/25
3-Month
52.45 +23.32%
on 03/07/25
Period Open: 59.03
117.33 -44.87%
on 03/31/25
+5.65 (+9.57%)
since 01/22/25
52-Week
22.00 +194.00%
on 04/25/24
Period Open: 22.30
117.33 -44.87%
on 03/31/25
+42.38 (+190.04%)
since 04/22/24

Most Recent Stories

More News
SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know

SoundHound AI, Domo, Plug Power, Corcept, and 8x8 Shares Are Falling, What You Need To Know

CORT : 64.68 (+2.83%)
SOUN : 8.14 (+8.53%)
PLUG : 0.8747 (+10.92%)
DOMO : 6.74 (-1.17%)
EGHT : 1.6300 (-0.61%)
3 Biopharmaceutical Stocks Bucking the Sell-Off

Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.

CORT : 64.68 (+2.83%)
DBVT : 8.75 (-1.80%)
SLRN : 2.34 (+2.63%)
ABBV : 173.78 (+2.13%)
ALMS : 4.97 (+5.74%)
Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Eli Lilly (NYSE:LLY) Vs The Rest Of The Branded Pharmaceuticals Stocks

CORT : 64.68 (+2.83%)
SUPN : 30.84 (+1.82%)
LLY : 827.54 (+1.16%)
ZTS : 149.99 (+2.14%)
BMY : 49.82 (+1.80%)
Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

Q4 Earnings Roundup: Organon (NYSE:OGN) And The Rest Of The Branded Pharmaceuticals Segment

CORT : 64.68 (+2.83%)
OGN : 11.24 (+5.74%)
SUPN : 30.84 (+1.82%)
MRK : 78.97 (+1.44%)
ZTS : 149.99 (+2.14%)
SNY Gets FDA Nod for First Ever Hemophilia Drug in the United States

Sanofi SNY and partner, Alnylam Pharmaceuticals ALNY, announced that the FDA has approved Qfitlia (fitusiran) as the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce...

BAYRY : 6.1700 (+4.40%)
CORT : 64.68 (+2.83%)
ALNY : 236.75 (+1.72%)
SNY : 51.85 (+1.81%)
Why Is Corcept (CORT) Stock Soaring Today

Why Is Corcept (CORT) Stock Soaring Today

CORT : 64.68 (+2.83%)
3 Reasons to Sell CORT and 1 Stock to Buy Instead

3 Reasons to Sell CORT and 1 Stock to Buy Instead

CORT : 64.68 (+2.83%)
TDG : 1,307.90 (+0.10%)
3 Growth Stocks in Hot Water

3 Growth Stocks in Hot Water

CORT : 64.68 (+2.83%)
NX : 16.09 (+3.81%)
SEM : 15.88 (+2.72%)
1 Small-Cap Stock on Our Buy List and 2 to Avoid

1 Small-Cap Stock on Our Buy List and 2 to Avoid

CORT : 64.68 (+2.83%)
SEMR : 9.25 (+3.01%)
NYT : 50.12 (+2.58%)
Corcept Shares Rise More Than 55% in 6 Months: Here's Why

Shares of Corcept Therapeutics Incorporated CORT have rallied 56.4% in the past six months against the industry’s decline of 10.5%.The company’s sole-marketed drug, Korlym (mifepristone), which is...

CORT : 64.68 (+2.83%)
JAZZ : 103.38 (+3.03%)
ANIP : 68.95 (+1.40%)
ORGO : 4.33 (+2.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 68.87
2nd Resistance Point 66.97
1st Resistance Point 65.83
Last Price 64.68
1st Support Level 62.79
2nd Support Level 60.89
3rd Support Level 59.75

See More

52-Week High 117.33
Fibonacci 61.8% 80.91
Fibonacci 50% 69.67
Last Price 64.68
Fibonacci 38.2% 58.42
52-Week Low 22.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro